New Delhi: Serum Institute of India (SII) is expected to sign a contract with the Central government to supply COVID-19 vaccine at Rs 250 per dose, Business Standard reported.
SII, which is the world’s largest vaccine producer, along with Pfizer India have applied for emergency approval of their vaccines in India.
SII CEO Adar Poonawalla had earlier revealed that the vaccine would be priced around Rs 1,000 per dose in the private market. He had also assured that the vaccine would be first supplied to Indians before exporting.
SII is producing the vaccine developed by AstraZeneca and Oxford University.
New Delhi: In a recent statement that has stirred political conversations, Shashi Tharoor reaffirmed his… Read More
Bhopal: Prime Minister Narendra Modi lashed out at critics of the Mahakumbh Mela at a… Read More
Balasore: With the festival of Maha Shivratri fast approaching, hectic preparations are underway at the… Read More
New Delhi: In a recent social media post, actress Kangana Ranaut sparked controversy by defending… Read More
Dubai: India restricted Pakistani to a manageable total in their Group A Champions Trophy clash,… Read More
Bhubaneswar: Hundreds of turtles being transported illegally were seized from a vehicle in Godipada area… Read More
This website uses cookies.
